the Neos brands are on a strong growth trajectory.”
Aytu’s existing portfolio includes a nasal testosterone spray for men, a spray sleep aid and a 12-hour codeine-based cough syrup. Its pediatric products range from antibiotics and allergy medication to supplements for infants and children with fluoride deficiency.
It also distributes COVID-19 rapid antibody and antigen tests, and recently licensed rights to develop an ultraviolet medical device as a treatment for the coronavirus and other respiratory infections. In addition, Aytu operates a consumer health subsidiary, Innovus Pharmaceuticals Inc., that develops and sells men’s and women’s health and vitality products direct to consumers.